BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

B. Olivier,; J. Mos,; D.L. Rasmussen,

doi:10.1515/DMDI.1990.8.1-2.31

Startseite BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

Artikel

Lizenziert

Nicht lizenziert Erfordert eine Authentifizierung

BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

B. Olivier, , J. Mos, und D.L. Rasmussen,

Veröffentlicht/Copyright: 1. Juni 1990

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Manuskript einreichen Informationen für Autor*innen

Aus der Zeitschrift Drug Metabolism and Drug Interactions Band 8 Heft 1-2

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Olivier,, B., Mos,, J. and Rasmussen,, D.L.. "BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE" Drug Metabolism and Drug Interactions, vol. 8, no. 1-2, pp. 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier,, B., Mos,, J. & Rasmussen,, D. (). BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE. Drug Metabolism and Drug Interactions, 8(1-2), 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier,, B., Mos,, J. and Rasmussen,, D. () BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE. Drug Metabolism and Drug Interactions, Vol. 8 (Issue 1-2), pp. 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier,, B., Mos,, J. and Rasmussen,, D.L.. "BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE" Drug Metabolism and Drug Interactions 8, no. 1-2 (): 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier, B, Mos, J, Rasmussen, D. BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE. Drug Metabolism and Drug Interactions. ;8(1-2): 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Kopie

In die Zwischenablage kopiert

BibTeX EndNote RIS

Published Online: 1990-06

Sie haben derzeit keinen Zugang zu diesem Inhalt.

Artikel in diesem Heft

TABLE OF CONTENTS
SERENICS: AN INTRODUCTION
ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS
BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE
NEUROCHEMICAL PROFILE OF ELTOPRAZINE
DISTRIBUTION OF RADIOACTIVELY LABELLED ELTOPRAZINE IN RAT AND DOG
THE METABOLITE PATTERNS OF ELTOPRAZINE IN MAN, DOG, RAT AND RABBIT
PHARMACOKINETICS OF ELTOPRAZINE IN THE DOG
PHARMACOKINETICS OF ELTOPRAZINE IN HEALTHY SUBJECTS
POSSIBLE CLINICAL APPLICATIONS OF SERENICS AND SOME IMPLICATIONS OF THEIR PRECLINICAL PROFILE FOR THEIR CLINICAL USE IN PSYCHIATRIC DISORDERS

Zeitschrift durchsuchen In dieser Zeitschrift suchen

https://doi.org/10.1515/DMDI.1990.8.1-2.31

Artikel in diesem Heft

TABLE OF CONTENTS
SERENICS: AN INTRODUCTION
ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS
BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE
NEUROCHEMICAL PROFILE OF ELTOPRAZINE
DISTRIBUTION OF RADIOACTIVELY LABELLED ELTOPRAZINE IN RAT AND DOG
THE METABOLITE PATTERNS OF ELTOPRAZINE IN MAN, DOG, RAT AND RABBIT
PHARMACOKINETICS OF ELTOPRAZINE IN THE DOG
PHARMACOKINETICS OF ELTOPRAZINE IN HEALTHY SUBJECTS
POSSIBLE CLINICAL APPLICATIONS OF SERENICS AND SOME IMPLICATIONS OF THEIR PRECLINICAL PROFILE FOR THEIR CLINICAL USE IN PSYCHIATRIC DISORDERS